TAM-EVs primarily affect tumor cells to undergo EMT by upregulating ABCA1 expression in MC-38 and CT-26 cells, decreasing cell membrane and intracellular cholesterol content, and potentially increasing membrane fluidity, which is closely associated with tumor cell metastasis (106). Here, ABCA1 is linked to neoplasm.